Comparative Pharmacology
Head-to-head clinical analysis: DIANEAL LOW CALCIUM W DEXTROSE 1 5 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 3 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIANEAL LOW CALCIUM W DEXTROSE 1 5 IN PLASTIC CONTAINER versus DIANEAL PD 2 W DEXTROSE 3 5 IN PLASTIC CONTAINER.
DIANEAL LOW CALCIUM W/DEXTROSE 1.5% IN PLASTIC CONTAINER vs DIANEAL PD-2 W/ DEXTROSE 3.5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dianeal Low Calcium with Dextrose 1.5% is a peritoneal dialysis solution that provides osmotic gradient for ultrafiltration and diffusion of solutes across the peritoneal membrane. Dextrose (1.5%) acts as the osmotic agent, creating a concentration gradient that drives water removal. The low calcium concentration (2.5 mEq/L) helps manage hypercalcemia in patients requiring calcium-based phosphate binders.
Dianeal PD-2 with Dextrose 3.5% is a peritoneal dialysis solution. Dextrose provides an osmotic gradient that facilitates the removal of uremic toxins and excess fluid from the blood across the peritoneal membrane into the dialysate. The solution also contains electrolytes to correct imbalances.
Intraperitoneal administration: 2 L per exchange, 4 exchanges per day (2.5 L per exchange for larger patients if tolerated).
2 to 3 liters intraperitoneally, 4 exchanges daily, with dwell times of 4-6 hours for CAPD; or 2 to 2.5 liters intraperitoneally, cycler-assisted, 3-5 cycles nightly for APD. Dextrose 3.5% solution used based on ultrafiltration needs.
None Documented
None Documented
For intraperitoneal dextrose: not clinically applicable as elimination is via continuous peritoneal dialysis. Systemically absorbed dextrose has a half-life of 15-20 minutes due to rapid cellular uptake and metabolism.
The elimination half-life of dextrose from the systemic circulation is approximately 3.5-4.5 hours after intraperitoneal administration. Clinically, this reflects the rate of glucose absorption and metabolism, which can be altered in patients with impaired glucose tolerance or diabetes.
Primarily removed via peritoneal dialysis itself; ~70% of absorbed glucose undergoes metabolism, with remaining glucose and lactate absorbed systemically and metabolized hepatically. Renal elimination of dextrose and lactate is negligible (<5%) due to low systemic absorption and endogenous metabolism.
Peritoneal dialysis (PD) with 3.5% dextrose solution results in elimination of excess fluid and solutes via the peritoneal membrane. Dextrose is absorbed systemically and metabolized. The primary route of elimination of dialytic waste products (e.g., urea, creatinine) is via the peritoneal fluid itself, which is drained. Less than 1% of dextrose is excreted unchanged in urine. Biliary/fecal excretion is negligible.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution